Navigation Links
Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Par Pharmaceutical Companies, Inc.
Date:7/19/2012

DALLAS, July 19, 2012 /PRNewswire/ -- Securities lawyers at Goldfarb LLP are investigating alleged violations of shareholder protection laws by officers and directors of Par Pharmaceutical Companies, Inc. (NYSE: PRX) in connection with a buyout for $50.00 per share to TPG Capital. Concerned PRX investors are encouraged to contact attorney Hamilton Lindley at 877-583-2855 or hlindley@goldfarbllp.com about their rights and remedies.

"Analysts have pegged the value of the company as high as $68 per share," Hamilton Lindley said. "Shareholders are owed the highest price reasonably available in a corporate buyout. Our potential shareholder claim seeks to ensure those fiduciary duties are enforced at the highest levels of the company."

Goldfarb LLP lawyers have significant experience representing shareholders and whistleblowers in securities lawsuits nationwide. PRX stockholders – or anyone with knowledge about this acquisition – should contact lawyer Hamilton Lindley at hlindley@goldfarbllp.com or 877-583-2855 with questions or concerns.

Hamilton Lindley
Goldfarb LLP
2501 N. Harwood, Ste. 1801
Dallas, TX 75201
(877) 583-2855 Toll Free Telephone
(214) 583-2233 Local Phone Number
(214) 583-2234 Fax Number
www.goldfarbllp.com

 


'/>"/>
SOURCE Goldfarb LLP
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. 3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference
2. Insmed To Present At JMP Securities 7th Annual Healthcare Conference
3. Anthera Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
4. Delcath To Present At JMP Securities Healthcare Conference On July 12
5. Arena Pharmaceuticals to Present at the Seventh Annual JMP Securities Healthcare Conference
6. Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference
7. Depomed To Present At JMP Securities 7th Annual Healthcare Conference
8. Solta Medical to Present at the JMP Securities Healthcare Conference
9. Vanda Pharmaceuticals to Present at the JMP Securities Healthcare Conference
10. Optimer Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
11. Uroplasty To Present At The JMP Securities Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Research and Markets has announced the addition of ... their offering. ... The Cell Therapy Manufacturing Market, 2017-2027 report provides an ... manufacturing and focuses both on contract manufacturers and cell therapy ... emerge as viable alternatives to conventional treatment options. ...
(Date:3/24/2017)... PUNE, India , March 24, 2017 According ... Market: Global Opportunity Analysis and Industry Forecast, 2014-2022," the spine bone stimulators market ... million by 2022, growing at a CAGR of 3.6% during the forecast period. ... ... Allied Market Research Logo ...
(Date:3/24/2017)... Calif. , March 24, 2017 /PRNewswire/ ... epigenetics company, and Hamilton Robotics, Inc., who ... announced an ongoing collaboration that teams Zymo ... and RNA and DNA extraction products with ... already created optimized methods for microbiomics and ...
Breaking Medicine Technology:
(Date:3/27/2017)... Clearwater, FL (PRWEB) , ... March 27, 2017 ... ... accepts new patients for clear braces. People who want straight teeth without the ... Invisalign® in Clearwater, FL, without acquiring a referral. A custom-designed series ...
(Date:3/27/2017)... VA (PRWEB) , ... March 27, 2017 , ... ... 3.0 was transitioned to the OSEHRA popHealth Community in 2014. It ... Work Group and the Developer Open Source Project Group. OSEHRA Organizational Member Zato ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... CE Certificate of Conformity for the Smart System® 20/20. CE Certification builds upon ... industry standards and specifications such as ANSI, ISO and proven test methods used ...
(Date:3/27/2017)... ... 27, 2017 , ... Advantexe Learning Solutions , a ... a new research study, The Business Readiness Report. The report explores the correlation ... the actual success of achieving individual and company goals. , There are ...
(Date:3/27/2017)... ... March 27, 2017 , ... According to the ... including all stages, is more than 95%. Once the cancer spreads to other organs, ... 30%. To find out how to avoid this latter group, tune in to ...
Breaking Medicine News(10 mins):